Zhejiang Hisoar Pharmaceutical Co Ltd Capital Reinvestment Ratio
Zhejiang Hisoar Pharmaceutical Co Ltd capital reinvestment ratio. Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Capital Reinvestment Ratio of 1.07x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.48 Million) in capital expenditures (CN¥16.52 Million). See 002099 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zhejiang Hisoar Pharmaceutical Co Ltd (2004–2024)
Capital reinvestment ratio of Zhejiang Hisoar Pharmaceutical Co Ltd from 2004 to 2024. This chart tracks Zhejiang Hisoar Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 21 annual periods. See 002099 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Zhejiang Hisoar Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2004–2024)
Zhejiang Hisoar Pharmaceutical Co Ltd capital reinvestment ratio by year from 2004 to 2024. For the full cash flow conversion analysis, see 002099 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.70x | CN¥174.83 Million | CN¥122.11 Million | ▲ +9.7% |
| 2023 | 0.64x | CN¥240.54 Million | CN¥153.08 Million | ▼ -58.8% |
| 2022 | 1.55x | CN¥116.09 Million | CN¥179.42 Million | ▼ -31.1% |
| 2021 | 2.24x | CN¥102.36 Million | CN¥229.56 Million | ▲ +1514.0% |
| 2020 | 0.14x | CN¥533.87 Million | CN¥74.18 Million | ▼ -47.0% |
| 2019 | 0.26x | CN¥612.40 Million | CN¥160.64 Million | ▼ -18.8% |
| 2018 | 0.32x | CN¥791.45 Million | CN¥255.78 Million | ▼ -77.7% |
| 2017 | 1.45x | CN¥102.68 Million | CN¥148.99 Million | ▲ +634.7% |
| 2016 | 0.20x | CN¥629.42 Million | CN¥124.31 Million | ▼ -69.2% |
| 2015 | 0.64x | CN¥462.16 Million | CN¥296.36 Million | ▼ -27.3% |
| 2014 | 0.88x | CN¥191.56 Million | CN¥169.06 Million | ▼ -80.9% |
| 2013 | 4.63x | CN¥60.85 Million | CN¥281.79 Million | ▲ +96.1% |
| 2012 | 2.36x | CN¥180.73 Million | CN¥426.79 Million | ▲ +0.5% |
| 2011 | 2.35x | CN¥92.62 Million | CN¥217.52 Million | ▲ +190.0% |
| 2010 | 0.81x | CN¥180.88 Million | CN¥146.51 Million | ▲ +48.7% |
| 2009 | 0.54x | CN¥98.38 Million | CN¥53.60 Million | ▼ -81.6% |
| 2008 | 2.95x | CN¥30.61 Million | CN¥90.40 Million | ▲ +34.1% |
| 2007 | 2.20x | CN¥51.14 Million | CN¥112.61 Million | ▲ +32.8% |
| 2006 | 1.66x | CN¥61.88 Million | CN¥102.59 Million | ▼ -18.9% |
| 2005 | 2.04x | CN¥36.07 Million | CN¥73.74 Million | ▲ +103.6% |
| 2004 | 1.00x | CN¥42.36 Million | CN¥42.54 Million | — |